<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Inference for Batched Adaptive Experiments - Health AI Hub</title>
    <meta name="description" content="This paper introduces the Batched Ordinary Least Squares (BOLS) test statistic to address challenges in causal inference for adaptive experiments, which are inc">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Inference for Batched Adaptive Experiments</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.10156v1" target="_blank">2512.10156v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-10
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Jan Kemper, Davud Rostam-Afschar
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> econ.EM, cs.LG, stat.ME
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.85 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.10156v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.10156v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces the Batched Ordinary Least Squares (BOLS) test statistic to address challenges in causal inference for adaptive experiments, which are increasingly adopted across various fields, including medicine. The BOLS statistic offers a precision-equalizing aggregation of per-period treatment-control differences, effectively handling heteroskedasticity. It enables the construction of asymptotically valid confidence intervals for treatment effects and has been validated through simulations comparing rejection rates in common experimental settings.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Adaptive experimental designs are increasingly prevalent in medical research, particularly in clinical trials and public health interventions. This paper provides a crucial statistical tool to ensure that treatment effect estimations from such adaptive designs are causally valid and robust, which is essential for making informed decisions about patient care, drug efficacy, and public health policies.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The statistical methods for inference in batched adaptive experiments are crucial for the development and validation of AI applications in healthcare. For instance, AI algorithms can guide adaptive clinical trials to optimize treatment arms or dose selection. Similarly, AI-driven personalized medicine strategies could be evaluated and refined using adaptive experimental designs that leverage these inference methods. The methodology is also applicable for A/B testing and evaluating the causal impact of AI-powered digital health interventions.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the significant challenge of achieving valid causal inference in adaptive experiments.</li>
                    
                    <li>Proposes the BOLS (batched ordinary least squares) test statistic for robust inference of treatment effects.</li>
                    
                    <li>The BOLS statistic performs a precision-equalizing aggregation of per-period treatment-control differences.</li>
                    
                    <li>Specifically designed to account for and manage heteroskedasticity in the data.</li>
                    
                    <li>Combines information into a normalized average of heteroskedastic per-period z-statistics.</li>
                    
                    <li>Can be used to construct asymptotically valid confidence intervals for treatment effects.</li>
                    
                    <li>Simulation results demonstrate its performance in typical scenarios, including those with few treatment periods and varying batch sizes (few or many observations per batch).</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The authors developed a novel statistical test statistic, BOLS (batched ordinary least squares), which performs a precision-equalizing aggregation of per-period treatment-control differences. This aggregation is achieved by computing a normalized average of heteroskedastic per-period z-statistics. The method's validity was assessed through simulations comparing rejection rates under conditions typical of adaptive experiments, specifically focusing on scenarios with limited treatment periods and varying batch sizes.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The BOLS test statistic provides a robust and asymptotically valid method for causal inference in adaptive experiments, successfully aggregating per-period treatment-control differences while accounting for heteroskedasticity. Simulation results support its effectiveness in yielding appropriate rejection rates, demonstrating its practical applicability even in situations with few treatment periods and diverse batch sizes.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This methodology can significantly enhance the statistical rigor and reliability of adaptive clinical trials, leading to more accurate and trustworthy conclusions regarding the efficacy and safety of new treatments and interventions. It facilitates more efficient and ethical trial designs by providing valid inference for decisions made based on accumulating data, ultimately supporting faster and more confident translation of research findings into clinical practice and public health policy.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract primarily describes the strengths and features of the proposed method. While it states that the confidence intervals are "asymptotically valid," implying reliance on large sample properties for theoretical guarantees, the abstract itself does not explicitly detail specific limitations or boundary conditions of the BOLS statistic beyond this theoretical underpinning. However, the simulation results specifically address performance in non-asymptotic settings (e.g., few treatment periods, few observations per batch).</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Future research directions are not explicitly mentioned in the provided abstract.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Clinical trials</span>
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Public health research</span>
                    
                    <span class="tag">Personalized medicine</span>
                    
                    <span class="tag">Health economics</span>
                    
                    <span class="tag">Epidemiology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Adaptive experiments</span>
                    
                    <span class="tag tag-keyword">Causal inference</span>
                    
                    <span class="tag tag-keyword">Batched experiments</span>
                    
                    <span class="tag tag-keyword">Treatment effects</span>
                    
                    <span class="tag tag-keyword">Heteroskedasticity</span>
                    
                    <span class="tag tag-keyword">Confidence intervals</span>
                    
                    <span class="tag tag-keyword">Statistical inference</span>
                    
                    <span class="tag tag-keyword">Clinical trials</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">The advantages of adaptive experiments have led to their rapid adoption in economics, other fields, as well as among practitioners. However, adaptive experiments pose challenges for causal inference. This note suggests a BOLS (batched ordinary least squares) test statistic for inference of treatment effects in adaptive experiments. The statistic provides a precision-equalizing aggregation of per-period treatment-control differences under heteroskedasticity. The combined test statistic is a normalized average of heteroskedastic per-period z-statistics and can be used to construct asymptotically valid confidence intervals. We provide simulation results comparing rejection rates in the typical case with few treatment periods and few (or many) observations per batch.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>